Blog

DAPASUG-VM-500 Tablets: Advanced Triple-Action Control for Type 2 Diabetes

• 21-02-2026

Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, reduced insulin secretion, and increased glucose production. When blood sugar levels remain uncontrolled with dual therapy, patients require a more comprehensive pharmacological approach that targets multiple glucose-regulating pathways simultaneously.

DAPASUG-VM-500 Tablets combine Dapagliflozin 10 mg + Vildagliptin 100 mg + Metformin Hydrochloride IP 500 mg (SR) to provide triple-mechanism glycemic control in adults with inadequately controlled Type 2 Diabetes.

---

Understanding the Composition of DAPASUG-VM-500 Tablets

Dapagliflozin 10 mg – SGLT2 Inhibitor

Dapagliflozin works by inhibiting Sodium-Glucose Co-Transporter-2 (SGLT2) in the kidneys. This reduces glucose reabsorption and promotes glucose excretion through urine.

Key benefits of Dapagliflozin:
? Lowers blood glucose levels effectively
? Promotes urinary glucose elimination
? Supports weight management
? Offers additional cardiovascular and renal benefits (as clinically established)

---

Vildagliptin 100 mg – DPP-4 Inhibitor

Vildagliptin enhances incretin hormone activity, stimulating insulin secretion and reducing glucagon release in a glucose-dependent manner.

Key benefits of Vildagliptin:
? Improves postprandial glucose control
? Enhances insulin secretion
? Reduces glucagon levels
? Low risk of hypoglycemia

---

Metformin Hydrochloride IP 500 mg (SR) – Insulin Sensitizer

Metformin SR reduces hepatic glucose production and improves peripheral insulin sensitivity.

Key benefits of Metformin SR:
? Decreases liver glucose output
? Improves insulin sensitivity
? Provides sustained glycemic control
? Better gastrointestinal tolerability due to sustained-release formulation

---

Indications of DAPASUG-VM-500 Tablets

DAPASUG-VM-500 Tablets are indicated:

• For the management of Type 2 Diabetes Mellitus in adults
• When blood sugar is not adequately controlled with dual therapy
• To improve overall glycemic control through multi-pathway action

This combination targets insulin resistance, impaired insulin secretion, and excessive glucose reabsorption simultaneously.

---

Why Choose DAPASUG-VM-500 Tablets?

1. Triple-Mechanism Action

Addresses three core defects in Type 2 Diabetes management.

2. Improved Treatment Compliance

Three antidiabetic agents in one tablet simplify therapy.

3. Sustained Glucose Control

Metformin SR ensures gradual and consistent glucose reduction.

4. Comprehensive Glycemic Support

Provides fasting and postprandial blood sugar control.

---

How DAPASUG-VM-500 Tablets Work

DAPASUG-VM-500 Tablets work by:

• Increasing glucose excretion through urine (Dapagliflozin)
• Enhancing insulin secretion and reducing glucagon (Vildagliptin)
• Reducing hepatic glucose production and improving insulin sensitivity (Metformin SR)

This synergistic action results in effective and sustained blood glucose management.

---

Dosage and Administration

Dosage:
• As prescribed by the healthcare professional

Administration Guidelines:
• Swallow whole with water
• Do not crush or chew (SR tablet)
• Preferably taken with meals

?? Regular monitoring of blood glucose is recommended during treatment.

---

Packing Details

• Composition: Dapagliflozin 10 mg + Vildagliptin 100 mg + Metformin Hydrochloride IP 500 mg (SR)
• Packing: 10 × 10
• Dosage Form: Tablet

---

Possible Side Effects of DAPASUG-VM-500 Tablets

The medication is generally well tolerated. Possible side effects may include:

• Gastrointestinal discomfort
• Increased urination
• Mild urinary tract infections
• Headache

Consult a healthcare professional if symptoms persist.

---

Who Can Benefit from DAPASUG-VM-500 Tablets?

? Adults with inadequately controlled Type 2 Diabetes
? Patients requiring combination therapy beyond dual treatment
? Individuals needing comprehensive glucose management
? Patients seeking convenient multi-drug therapy

---

Why Healthcare Professionals Recommend DAPASUG-VM-500 Tablets

Healthcare professionals prefer DAPASUG-VM-500 Tablets because they:

• Offer triple-action glycemic control
• Combine three evidence-based antidiabetic agents
• Improve treatment adherence
• Address multiple pathophysiological defects of diabetes

---

Conclusion: Comprehensive Glycemic Management with DAPASUG-VM-500 Tablets

If you are looking for:

? Advanced blood sugar control
? Triple-mechanism diabetes management
? Improved insulin function and glucose regulation

DAPASUG-VM-500 Tablets provide a clinically effective and comprehensive approach to managing Type 2 Diabetes Mellitus.